Stay updated on Midostaurin + Chemotherapy in FLT3-MN AML Clinical Trial
Sign up to get notified when there's something new on the Midostaurin + Chemotherapy in FLT3-MN AML Clinical Trial page.

Latest updates to the Midostaurin + Chemotherapy in FLT3-MN AML Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision: v3.6.3 replaces the previous v3.6.2 tag, indicating an updated version of the page content. This reflects a metadata update rather than a substantive change to study details.SummaryDifference0.0%

- Check18 days agoChange DetectedThe page revision label was updated to v3.6.2, indicating a minor maintenance update to the page's metadata.SummaryDifference0.0%

- Check25 days agoChange DetectedPublications section added with a PubMed-cited paper by Sechaud et al. and a note that publications are auto-filled from PubMed. This provides external references and author attribution within the study details.SummaryDifference0.1%

- Check33 days agoChange DetectedThe page now shows 'No longer looking for participants,' updating the recruitment status. New sections 'How to Read a Study Record,' 'Common Questions,' and 'How to Join a Study' were added, and the Intervention/Treatment heading was standardized while an older 'Intervention / Treatment' heading and the revision tag were removed.SummaryDifference0.2%

- Check40 days agoChange DetectedRevision: v3.5.5 is now displayed on the page, replacing the previous Revision: v3.5.4. This represents a minor platform update that affects only the page’s version label and does not modify study content or functionality.SummaryDifference0.0%

- Check61 days agoChange DetectedRevision changed from v3.5.3 to v3.5.4, indicating an updated build/version of the page. This metadata update does not modify the study information or visible content.SummaryDifference0.0%

Stay in the know with updates to Midostaurin + Chemotherapy in FLT3-MN AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Midostaurin + Chemotherapy in FLT3-MN AML Clinical Trial page.